Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: bioavailability

May 22, 2023 E-ducation / Events / Pharma applications

Ashland webinar — the magic rings: how cyclodextrins can enable drug development

Ashland organizes a webinar on the following dates and times: • NA/LATAM: Wednesday, June 14 at 10:00 a.m. EDT• EMEA/APAC:

Continue reading

July 20, 2022 Drug delivery / Pharma applications

Melatonin/Cyclodextrin Inclusion Complexes: A Review

Melatonin (MLT) is involved in many functions of the human body, mainly in sleeping-related disorders. It also has anti-oxidant potential

Continue reading

February 9, 2022 CD as API / Drug delivery / Pharma applications

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as

Continue reading

January 27, 2022 Drug delivery / Pharma applications

Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial

Fat-soluble vitamin deficiency remains a challenge in cystic fibrosis (CF), chronic pancreatitis, and biliary atresia. Liposomes and cyclodextrins can enhance

Continue reading

December 7, 2021 Drug delivery / Pharma applications

γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis

Anterior uveitis is a sight-threatening inflammation inside the eyes. Conventional eye drops for anti-inflammatory therapy need to be administered frequently

Continue reading

May 7, 2021 Food / Non-pharma applications / Uncategorized

CAVACURMIN®: Study Reveals Increased Metabolic Bioavailability of Tetrahydrocurcumin

A study recently published in the Journal of Functional Foods shows that ingestion of the curcumin-cyclodextrin complex CAVACURMIN® leads to an

Continue reading

March 3, 2021 Drug delivery / Pharma applications

Improving Bioavailability & Solubility

Drug Development & delivery published on the virtual 2020 Global Drug Bioavailability Enhancement Summit, which this past December showcased novel

Continue reading

June 9, 2020 Agriculture / CD derivatives

Use of cyclodextrins as agrochemical delivery system

ADAMA MAKHTESHIM LTD. (Israel) filed a PCT patent application (WO2020084572) that was recently published. The invention relates to preparation and use

Continue reading

October 17, 2019 Food

WACKER Confers Innovation Award for Development of CAVACURMIN®

Munich-based chemical group WACKER has conferred the Alexander Wacker Innovation Award on Rachela Mohr and Dr. Helmut Reuscher for developing

Continue reading

March 25, 2019 Pharma applications

Phase I clinical trial posted on Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection

This study is designed to compare the bioavailability of the test Product (CE-Iohexol Injection) and the reference product Iohexol Injection

Continue reading

Posts navigation

1 2 Next Posts»

Recent Posts

  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Cyclodextrin in Vaccines
  • Special Issue “New Advances in Green Extraction Technology for Natural Products”
  • Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
  • Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (17)
  • Analysis (39)
  • CD as API (229)
  • CD derivatives (287)
  • Cosmetics and toilettry (22)
  • Diagnosis (2)
  • Drug delivery (499)
  • E-ducation (59)
  • Environmental (84)
  • Events (167)
  • Food (138)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (21)
  • Non-pharma applications (250)
  • Other industrial use (74)
  • Pharma applications (783)
  • Supramolecular systems (30)
  • Uncategorized (56)

Top Posts

  • Cyclodextrin in Vaccines
  • BioNTech's new invention: CD as potential cryoprotectant in lipid-based RNA formulation
  • Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins
  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Lanosterol eye drops for cataract treatment
  • Ashland webinar — the magic rings: how cyclodextrins can enable drug development
  • How air fresheners work?
  • Curcumin/amphiphilic cyclodextrin nanoassemblies: Theoretical andspectroscopic studies to address their debut in anticancer therapy
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 565 other subscribers
 

Loading Comments...